Wen-Jeng Wu

发表

Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma

Wen-Ren Wu, Jen-Tai Lin, Cheng-Tang Pan, 2020, Theranostics.

TG-interacting factor mediates arsenic-induced malignant transformation of keratinocytes via c-Src/EGFR/AKT/FOXO3A and redox signalings

Wen-Jeng Wu, Bi-Wen Yeh, Zi-Miao Liu, 2014, Archives of Toxicology.

Biomimetic polymer-based Ag nanocomposites as a antimicrobial platform

Wen-Jeng Wu, Bi-Wen Yeh, Deng-Chyang Wu, 2016 .

Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis

Wen-Jeng Wu, Deng-Chyang Wu, Sheau-Fang Yang, 2019, Oncogene.

Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to rapidly screen for albuminuria.

Wen-Jeng Wu, Deng-Chyang Wu, J. Shiea, 2008, Rapid communications in mass spectrometry : RCM.

Transmembrane and Coiled-Coil Domain 1 Impairs the AKT Signaling Pathway in Urinary Bladder Urothelial Carcinoma: A Characterization of a Tumor Suppressor

Wen-Ren Wu, T. Chan, Wen-Jeng Wu, 2017, Clinical Cancer Research.

CS-PEI/Beclin-siRNA Downregulate Multidrug Resistance Proteins and Increase Paclitaxel Therapeutic Efficacy against NSCLC

Wen-Jeng Wu, Z. Liao, Chien-Chih Chiu, 2019, Molecular therapy. Nucleic acids.

Silver decorated copper oxide (Ag@CuO) nanocomposite enhances ROS-mediated bacterial architecture collapse.

Y. Chen, Wen-Jeng Wu, Bi-Wen Yeh, 2017, Colloids and surfaces. B, Biointerfaces.

ATR-Chk 1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer

Y. Wu, F. Chang, Wen-Jeng Wu, 2016 .

Optimal usage of radium-223 in metastatic castration-resistant prostate cancer.

Wen-Jeng Wu, Chao-yuan Huang, Chia‐Chi Lin, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Biomarker Characterization by MALDI-TOF/MS.

M. Hou, Wen-Jeng Wu, Deng-Chyang Wu, 2015, Advances in clinical chemistry.

ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer

Y. Wu, F. Chang, Wen-Jeng Wu, 2015, Oncotarget.

Heteronemin Is a Novel c‐Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells

Y. Chou, Wen-Jeng Wu, Deng-Chyang Wu, 2016, The Prostate.

TG-interacting factor mediates arsenic-induced malignant transformation of keratinocytes via c-Src/EGFR/AKT/FOXO3A and redox signalings

Wen-Jeng Wu, Bi-Wen Yeh, Huei-Sheng Huang, 2015, Archives of Toxicology.

Glycine N-methyltransferase inhibits aristolochic acid nephropathy by increasing CYP3A44 and decreasing NQO1 expression in female mouse hepatocytes

Wen-Jeng Wu, Bi-Wen Yeh, Wei‐Ming Li, 2018, Scientific Reports.

The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma

Cheng-Tang Pan, T. Chan, Wen-Jeng Wu, 2023, Cellular Oncology.

Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis

T. Chan, Wen-Jeng Wu, Chien-Feng Li, 2021, Clinical and translational medicine.

ATF3 inhibits the growth and stem cells-like features of SW620 colorectal cancer cells in vitro

Wen-Jeng Wu, Chang-Han Chen, Jianfang Lin, 2021 .

Matrix-assisted laser desorption ionization/time-of-flight mass spectrometry for clinical diagnosis.

Wen-Jeng Wu, Deng-Chyang Wu, J. Shiea, 2013, Clinica chimica acta; international journal of clinical chemistry.

The protoapigenone analog WYC0209 targets CD133+ cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy.

Wen-Jeng Wu, Bi-Wen Yeh, Yang-Chang Wu, 2020, Toxicology and applied pharmacology.

Off-Resonance SERS Nanoprobe-Targeted Screen of Biomarkers for Antigens Recognition of Bladder Normal and Aggressive Cancer Cells.

Wen-Jeng Wu, Tsung-Ju Li, Chih-Chia Huang, 2019, Analytical chemistry.

Withaferin a Triggers Apoptosis and DNA Damage in Bladder Cancer J82 Cells through Oxidative Stress

Hsueh-Wei Chang, Wen-Jeng Wu, Bi-Wen Yeh, 2021, Antioxidants.

TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.

Wen-Jeng Wu, Bi-Wen Yeh, Huei-Sheng Huang, 2015, Toxicology and applied pharmacology.

Zingerone Nanotetramer Strengthened the Polypharmacological Efficacy of Zingerone on Human Hepatoma Cell Lines.

Wen-Jeng Wu, Bi-Wen Yeh, M. Tai, 2019, ACS applied materials & interfaces.

Nanoscale characterization illustrates the cisplatin-mediated biomechanical changes of B16-F10 melanoma cells.

Wen-Jeng Wu, Bi-Wen Yeh, Deng-Chyang Wu, 2016, Physical chemistry chemical physics : PCCP.

Diagnosis of albuminuria by tryptic digestion and matrix-assisted laser desorption ionization/time-of-flight mass spectrometry.

Wen-Jeng Wu, Deng-Chyang Wu, J. Shiea, 2013, Clinica chimica acta; international journal of clinical chemistry.

Transmembrane and Coiled-Coil Domain 1 Impairs the AKT Signaling Pathway in Urinary Bladder Urothelial Carcinoma: A Characterization of a Tumor Suppressor

Wen-Ren Wu, T. Chan, Wen-Jeng Wu, 2017, Clinical Cancer Research.